TO THE EDITOR
Schneckenbecken dysplasia [OMIM 269250 ] is an autosomal recessive, perinatal lethal skeletal dysplasia that was first characterized by [Borochowitz et al., 1986] , and is phenotypically similar to affected individuals in a family described by Knowles et al. [1986] . Clinical findings include relative macrocephaly, a very flat midface, cleft palate, a short neck, a narrow thorax, brachydactyly, and a high incidence of polyhydramnios. The most characteristic radiographic abnormality, as viewed on an anterior-posterior radiograph, is a medial projection from the ilia that resembles a snail (thus snail pelvis or Schneckenbecken in German). Additional findings include handlebar clavicles, a hypoplastic scapula, generalized platyspondyly with small, rounded vertebral bodies, very short long bones with relatively widened metaphyses and precociously ossified carpal and tarsal bones [Borochowitz et al., 1986; Nikkels et al., 2001] . [Warman et al., 2011] . Mutations in SLC35D1 [OMIM 610804 ], the gene encoding the Solute Carrier Family 35 UDP-Glucuronic Acid/ UDP-NAcetylgalactosamine Dual Transporter, Member D1, were found in 2 of 6 cases of Schneckenbecken dysplasia [Hiraoka et al., 2007] . In a subsequent report SLC35D1 mutations were identified in another three of five Schneckenbecken dysplasia cases but were absent among 15 cases of other severe spondylodysplastic skeletal dysplasias [Furuichi et al., 2009] . Most of the SLC35D1 mutations were predicted to lead to absence of the protein.
SLC35D1 has been localized to the endoplasmic reticulum (ER) where it translocates two nucleotide sugars, UDP-glucuronic acid and UDP-N-acetylgalactosamine, into microsomal membrane vesicles to be used in the synthesis of chondroitin sulfate [Muraoka et al., 2001] . A mouse deficient for Slc35d1 showed a phenotype similar to Schneckenbecken dysplasia and had defective chondroitin sulfate synthesis on the core protein of cartilage proteoglycans [Hiraoka et al., 2007] .
Under an approved human subjects protocol, exome sequence analysis using a previously described pipeline [Lee et al., 2012] was carried out in a case of Schneckenbecken dysplasia (International Skeletal Dysplasia Registry reference number R02-170) in which SLC35D1 was previously excluded (subject 4 in [Hiraoka et al., 2007] ). The case presented as a 33 week gestation hydropic stillborn. The radiographic findings were characteristic for Schneckenbecken dysplasia and included midface hypoplasia, handlebar clavicles, short ribs, hypoplastic vertebrae with rounded anterior ends, short long bones with widened metaphyseal ends and a snail-like medial projection in the ileum (Fig. 1) .
Analysis of the exome identified homozygosity for a variant, c.2415+1G>A in intron 21 of INPPL1 [OMIM 600829], which encodes Inositol Polyphosphate Phosphatase-like 1. The mutation predicts skipping of exon 21, which would lead to a frameshift and a premature termination codon. Recessively inherited mutations in INPPL1 also produce opsismodysplasia [OMIM 258480], another severe autosomal recessive spondylodysplastic disorder [Below et al., 2013; Huber et al., 2013] . Opsismodysplasia is generally non-lethal and is characterized by dysmorphic craniofacial features, a large anterior fontanelle, short stature and small hands and feet. Radiographic findings include very delayed bone maturation particularly at the knee, marked shortness of the metacarpals/ metatarsals and phalanges with metaphyseal cupping and markedly flat vertebral bodies [Cormier-Daire et al., 2003; Maroteaux et al., 1984] . Some affected individuals have severe renal phosphate wasting and there are variable degrees of respiratory insufficiency [Below et al., 2013] which may be secondary to the skeletal manifestations. A variety of other clinical findings have been described but an insufficient number of cases have been studied to know whether these are consistently associated with INPPL1 mutations. The c.2415+1G>A mutation found in the homozygous state in this case of Schneckenbecken dysplasia was also identified in a surviving opsismodysplasia case in compound heterozygosity with a frameshift mutation. Thus, apparent loss of INPPL1 function can produce either the perinatal lethal Histomorphology on the cartilage growth plate was performed by staining the tissue with toluidine blue and Goldner's reagent. The findings included poor hypertrophic column formation ( Fig. 2A) with fibrous septae between the columns, areas of hypercellularity with decreased extracellular matrix and hypervascularity (Fig. 2B) , chondrocytes with central round nuclei (Fig. 2C) , as well as thickened primary trabeculae and a fibrous band entering the growth plate from the bone collar (Fig. 2D) . With the exception of the dense fibrous band in the growth plate, these findings have been previously described in Schneckenbecken dysplasia [Varkey and Jones, 2004] , but the gene(s) involved were unknown. Similar findings were described in the Slc35d1 knockout mice as well as a Schneckenbecken dysplasia case due to defects in SLC35D1 [Hiraoka et al., 2007] . The histopathology in opsismodysplasia [Cormier-Daire et al., 2003 ] is similar, showing poorly organized growth plates, numerous vascular canals, increased chondrocyte density, and many round, ballooned chondrocytes and thickened trabeculae in the mineralized matrix. Thus the growth plate findings, while not necessarily pathognomonic for either Schneckenbecken dysplasia or opsismodysplasia, do show significant overlap. The only finding in this case that is distinct is the fibrous band that extends from the bone collar.
The similarities in the growth plates between this case of Schneckenbecken dysplasia due to homozygosity for an INPPL1 mutation and those due to SLC35D1 mutations could suggest possible mechanistic overlap. Defects in both genes could lead to reduced extracellular matrix synthesis and a hypercellular matrix containing chondrocytes with central nuclei. In cases due to SLC35D1 mutations, reduced post-translational modification of matrix proteoglycans appears to be the underlying abnormality. How defects in INPPL1 affect extracellular matrix production is unknown, but signaling cascades mediated by phosphatidylinositols including PI(3,4,5)P3 might contribute to matrix production and regulation.
The functional role of INPPL1 in skeletal biology is unknown. The protein is an inositol-1,4,5-trisphosphate 5-phosphatase and through its phosphatase activity converts phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) to PtdIns(3,4)P2. PtdIns-(3,4,5)P3 is widely expressed and acts as second messenger that participates in numerous cellular functions [Riehle et al., 2013] . Mouse models show that Inppl1 is a negative regular of insulin sensitivity and signaling and mice deficient for Inppl1 are small and have craniofacial abnormalities [Sleeman et al., 2005; Dubois et al., 2012] , implying a yet uncharacterized effect on skeletogenesis.
Our findings identify a second locus for Schneckenbecken dysplasia and demonstrate that the phenotype is part of an INPPL1 allelic spectrum of disease. It remains to be determined whether the remaining SLC35D1 negative cases harbor mutations in INPPL1 or whether there is further locus heterogeneity in this disorder. 
